AGTC

Applied Genetic Technologies Corporation AGTC

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode AGTC MRNS HARP FRLN MTCR SER ALLK KA ANGN AXLA
6M -11.03 % -60.43 % 516.89 % 73.07 % 31.84 % -58.78 % -68.66 % 18.21 % 23.21 % 0.00 %
YTD 0.00 % 3.00 % 109.18 % 1.56 % 30.13 % -52.16 % -73.46 % -83.10 % 14.69 % 0.00 %
1Y -83.93 % -76.29 % 257.30 % 3.02 % 5.71 % -53.79 % -71.63 % -83.49 % -10.71 % 0.00 %
3Y -92.02 % -70.11 % -89.54 % -96.77 % -95.06 % -87.58 % -88.29 % -98.76 % -94.12 % -89.71 %
5Y -89.78 % -58.96 % -81.81 % -97.60 % -95.06 % -95.86 % -99.55 % -99.28 % -94.12 % -96.03 %
10Y -97.33 % -94.72 % -82.96 % -97.60 % -95.06 % -97.48 % -98.95 % -99.92 % -94.12 % -98.67 %
From the beginning -97.33 % -93.13 % -82.96 % -97.60 % -95.06 % -97.48 % -98.95 % -99.92 % -94.12 % -98.67 %

Dividend

Metacrine, Inc.

Kineta, Inc.